Review
Published on 18 Aug 2022
Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.943154
- 4,698 views
- 4 citations



